What is the appropriate treatment for a patient with low plasma ACTH (<1.7 pg/mL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment for Low Plasma ACTH (<1.7 pg/mL)

A low plasma ACTH (<1.7 pg/mL) indicates secondary (central) adrenal insufficiency requiring lifelong glucocorticoid replacement with hydrocortisone at 10-20 mg/day in adults, divided into 2-3 doses with the highest dose in the morning—mineralocorticoid replacement is NOT needed. 1

Glucocorticoid Replacement Protocol

Adults

  • Start hydrocortisone 10-20 mg/day (lower than the 15-25 mg/day used for primary adrenal insufficiency) 1
  • Divide into 2-3 daily doses, with approximately 2/3 given in the morning and 1/3 in early afternoon to mimic physiological cortisol rhythm 2
  • Do NOT use fludrocortisone in secondary adrenal insufficiency—mineralocorticoid production remains intact as the renin-angiotensin-aldosterone system is independent of ACTH 1

Children

  • Hydrocortisone 8-10 mg/m²/day (lower dose than primary adrenal insufficiency) 1
  • Divide into 3-4 doses, especially in infants and young children 1
  • Higher doses (10-12 mg/m²/day) may be needed in babies prior to weaning 1

Critical Management Points

Avoid Long-Acting Glucocorticoids

First-generation long-acting glucocorticoids (prednisolone, dexamethasone) should be avoided except when hydrocortisone proves ineffective due to pharmacokinetic issues 1. These agents carry higher risk of adverse effects and lack flexibility for dose titration 2.

Stress Dosing Education

All patients require immediate education on:

  • Doubling or tripling oral hydrocortisone during minor illness (fever, infection, gastroenteritis) 1
  • Administering parenteral hydrocortisone for severe illness/inability to take oral medication 1
  • Carrying emergency injectable hydrocortisone and medical alert identification 1, 2

Adrenal Crisis Management

If the patient presents acutely ill:

  • Immediate IV/IM hydrocortisone 100 mg bolus without waiting for confirmatory testing 3
  • Continuous IV infusion 100 mg/24h (or 25 mg IV/IM every 6 hours) 1, 2
  • IV isotonic saline rehydration (at least 1-2 liters in first hour for adults) 1
  • Monitor and correct hypoglycemia with 5-10% dextrose as needed 1

In children with adrenal crisis:

  • Hydrocortisone 2 mg/kg every 6-8 hours IV/IM 2, 1
  • Aggressive fluid resuscitation with glucose-containing solutions 2, 1

Monitoring and Follow-Up

Clinical monitoring takes precedence over biochemical parameters in secondary adrenal insufficiency. Assess for:

  • Signs of under-replacement: persistent fatigue, weight loss, hypotension, hypoglycemia
  • Signs of over-replacement: weight gain, hypertension, hyperglycemia, cushingoid features, thin skin, easy bruising 1

Reduce maintenance dosing if iatrogenic Cushing's syndrome develops 4. The goal is the lowest tolerable dose that prevents symptoms of adrenal insufficiency 1.

Key Pitfall to Avoid

The most critical error is prescribing fludrocortisone in secondary adrenal insufficiency. Unlike primary adrenal insufficiency where both glucocorticoid and mineralocorticoid production fail, secondary adrenal insufficiency affects only cortisol production—aldosterone secretion remains normal because it's primarily regulated by the renin-angiotensin system, not ACTH 1, 5. Adding unnecessary fludrocortisone increases risk of hypertension, edema, and hypokalemia.

Surgical/Major Stress Coverage

For major surgery or severe illness:

  • 100 mg IV/IM hydrocortisone bolus at induction 1
  • Continuous infusion 100 mg/24h (or 25 mg every 6 hours) until oral intake resumes 1
  • Triple usual oral dose (minimum 60 mg/day) when transitioning back to oral therapy, then taper over several days 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.